Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates an update to the study page or template version rather than to any trial content.SummaryDifference0.0%

- Check26 days agoChange DetectedThe study record now shows the trial as Completed and adds a publication on HRQOL and symptom impact in CheckMate 9ER.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, signaling a small editorial update rather than a substantive change to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a minor update to the page’s documentation without changing the primary study details.SummaryDifference0.0%

- Check76 days agoChange DetectedA new publication citation about the final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma has been added to the Publications section. The document revision has been updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check83 days agoChange DetectedPlatform revision updated from v3.6.0 to v3.6.2, representing an underlying system update that does not affect the displayed study information.SummaryDifference0.0%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.